🇺🇸 FDA
Patent

US 7645441

Compositions and methods in cancer associated with altered expression of PRLR

granted A61PA61P35/00

Quick answer

US patent 7645441 (Compositions and methods in cancer associated with altered expression of PRLR) held by Sagres Discovery, Inc. expires Mon Jan 07 2030 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Sagres Discovery, Inc.
Grant date
Tue Jan 12 2010 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 07 2030 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61P, A61P35/00